Fundraising FoxM. James Barrett
InvestorGeneral Partner at New Enterprise Associates (NEA)
Morristown, New Jersey, United States
Find your path to M. James Barrett
Sign up to see every warm intro you have to M. James Barrett
- Paths you didn't know you had: your email and LinkedIn already hold routes to M. James Barrett. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
M. James Barrett is a venture capital investor who joined New Enterprise Associates (NEA) as a General Partner in 2001, where he focuses on biotechnology and collaborates with the firm's healthcare investment group on medical devices and specialty pharmaceutical companies. Before entering venture capital, he founded and led Sensors for Medicine and Science, serving as its Chairman and CEO from 1997 to 2001. Earlier in his career he ran several NEA-funded companies, including Genetic Therapy, Inc. as Chairman and CEO, Life Technologies as President and CEO, and Bethesda Research Labs as President and CEO. He also worked in various divisions of SmithKline prior to 1982. He has held board roles at companies including GlycoMimetics, Clovis Oncology, PhaseBio Pharmaceuticals, Psyadon Pharmaceuticals, Roka Bioscience, and Senseonics. He holds a Ph.D. in biochemistry, an M.B.A., and a B.S. in chemistry.
Beyond investing
- Founded
- Barrett founded Sensors for Medicine and Science, serving as its Chairman and CEO from 1997 to 2001.
- Education
- Studied at University of Tennessee (Ph.D., Biochemistry) Studied at University of Santa Clara (M.B.A.) Studied at Boston College (B.S., Chemistry)
From published sources — common ground for a warm intro.
Investments
Board seats
Clovis OncologyGlycomimeticsPhaseBio PharmaceuticalsPsyadon PharmaceuticalsRoka BioscienceSenseonics
Per curated public sources.
Colleagues at New Enterprise Associates (NEA)
Frequently asked questions
- Who is M. James Barrett?
- M. James Barrett is a venture capital investor who joined New Enterprise Associates (NEA) as a General Partner in 2001, where he focuses on biotechnology and collaborates with the firm's healthcare investment group on medical devices and specialty pharmaceutical companies. Before entering venture capital, he founded and led Sensors for Medicine and Science, serving as its Chairman and CEO from 1997 to 2001. Earlier in his career he ran several NEA-funded companies, including Genetic Therapy, Inc. as Chairman and CEO, Life Technologies as President and CEO, and Bethesda Research Labs as President and CEO. He also worked in various divisions of SmithKline prior to 1982. He has held board roles at companies including GlycoMimetics, Clovis Oncology, PhaseBio Pharmaceuticals, Psyadon Pharmaceuticals, Roka Bioscience, and Senseonics. He holds a Ph.D. in biochemistry, an M.B.A., and a B.S. in chemistry.
- Where does M. James Barrett work?
- M. James Barrett is General Partner at New Enterprise Associates (NEA).
- What boards does M. James Barrett sit on?
- M. James Barrett holds tracked board seats at Clovis Oncology, Glycomimetics, PhaseBio Pharmaceuticals, Psyadon Pharmaceuticals, Roka Bioscience, Senseonics.
About this profile. Compiled from public sources — New Enterprise Associates (NEA)'s own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights